Analysis of the treatment of AECOPD patient complicated with high-risk case of Pseudomonas aeruginosa and immunocompromised condition / 药学实践杂志
Journal of Pharmaceutical Practice
; (6): 370-372, 2015.
Article
in Zh
| WPRIM
| ID: wpr-790489
Responsible library:
WPRO
ABSTRACT
Objective To investigate risk factors for Pseudomonas aeruginosa infected AECOPD patients and the signifi-cance of immune regulation .Methods The clinical pharmacist is involved in the administration and guardianship of immuno-compromised patients with recurrent AECOPD .The clinical pharmacist provides recommendations and theoretical support in antimicrobial drug selection and regulating immunity .Results Clinical pharmacist gave rationalized medication recommenda-tions .It made anti-infective programs more reasonable and effective .Conclusion By assisting physicians in formulating regi-mens ,clinical pharmacists can provide more optimal individualized treatment for patients .
Full text:
1
Database:
WPRIM
Type of study:
Etiology_studies
/
Guideline
/
Risk_factors_studies
Language:
Zh
Journal:
Journal of Pharmaceutical Practice
Year:
2015
Document type:
Article